Constrictive (obliterative) bronchiolitis
small-airway fibrosis · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Constrictive bronchiolitis is irreversible small-airway fibrosis causing fixed airflow obstruction, seen after lung/stem-cell transplant, connective-tissue disease, toxic inhalation and certain infections. It often progresses despite treatment; early recognition and cause-directed therapy are key.
Red flags
- Rapid FEV1 decline
- Hypoxaemia / respiratory failure
- Post-transplant: features of chronic rejection
- Recurrent infection superimposed on fixed obstruction
Assessment
Differential diagnosis
- Asthma / COPD
- Bronchiectasis
- Hypersensitivity pneumonitis
- Chronic lung allograft dysfunction (post-transplant)
- Diffuse panbronchiolitis
Investigations
- Spirometry (fixed obstructive pattern, often with air trapping)
- Expiratory HRCT (mosaic attenuation, air trapping, bronchial wall thickening)
- Lung volumes and DLCO
- History of transplant, connective-tissue disease, inhalational exposure or infection
- Lung biopsy in selected diagnostic uncertainty
Management
- Suspect in progressive fixed airflow obstruction not explained by asthma/COPD
- Document the obstructive physiology and air trapping on expiratory CT
- Identify the underlying cause (allograft rejection, GVHD, connective-tissue disease, toxic inhalation)
- In transplant/stem-cell recipients, evaluate for chronic allograft dysfunction / GVHD
- Optimise bronchodilator therapy (limited benefit but worth a trial)
- Treat the underlying cause and modify immunosuppression where relevant
- Trial azithromycin for its anti-inflammatory/immunomodulatory effect
- Provide supportive care, pulmonary rehabilitation and oxygen assessment
- Monitor lung function trajectory for progression
- Refer progressive disease for lung transplant / re-transplant assessment
Drugs & doses
Azithromycin 250-500 mg PO three times weekly (immunomodulatory)
Inhaled LABA-LAMA +/- ICS as a trial
Optimise/modify systemic immunosuppression for post-transplant/GVHD disease
Montelukast / inhaled corticosteroid as adjuncts in selected cases
Disposition
Specialist respiratory / transplant clinic; cause-directed therapy; transplant assessment for progressive disease.
Complications & pitfalls
- Progressive irreversible airflow obstruction
- Respiratory failure
- Recurrent infection
- Graft loss in transplant recipients
Exam pearls
- It causes fixed obstruction with minimal bronchodilator reversibility, distinguishing it from asthma
- Expiratory CT air trapping and mosaicism are key radiological clues
- Azithromycin may stabilise post-transplant bronchiolitis obliterans syndrome
- Toxic inhalational exposures (e.g. diacetyl, nitrogen oxides, sulfur mustard) are classic causes
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.